Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-26T17:29:01.281Z Has data issue: false hasContentIssue false

Severe Acute Respiratory Syndrome Coronavirus 2 and Dengue Virus Co-infection: Indian Perspectives

Published online by Cambridge University Press:  04 August 2021

U. Venkatesh*
Affiliation:
Department of Community Medicine, Vardhman Mahavir Medical College (VMMC) & Safdarjung Hospital, New Delhi, India
Pranav Ish
Affiliation:
Department of Pulmonary, Critical Care and Sleep Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India
Shilpi Kumari
Affiliation:
Department of Microbiology, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India
Nitesh Gupta
Affiliation:
Department of Pulmonary, Critical Care and Sleep Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India
Akash Sharma
Affiliation:
University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India
*
Corresponding author: Venkatesh U, Email: [email protected].

Abstract

Severe acute respiratory syndrome Coronavirus 2 (SARS CoV-2) and Dengue virus (DENV) Coinfection can be a pertinent issue in a country like India, where Dengue is endemic, and Coronavirus disease 19 (COVID-19) is also reported from all states of the country. The coinfection of these viruses has already been reported in different dengue‐endemic countries like Singapore, Thailand, and Bangladesh. The outcome and the dynamics of each of the diseases may be altered in the presence of coinfection. We highlighted the critical characteristic similarities and differences between COVID-19 and Dengue infection & the specific point, which may challenge diagnosing and managing these coinfections. COVID-19 and Dengue coinfection can be deadly in combination with an atypical presentation, providing diagnostic and therapeutic challenges. A high index of suspicion, early recognition of symptoms, and warning signs are vital to prevent double jeopardy.

Type
Commentary
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of Society for Disaster Medicine and Public Health, Inc.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Radisic, MV, Piro, MA, Mori, I, et al. SARS-CoV-2 and dengue virus co-infection. A case report. Hemoglobin. 2020;28(3):416-419.Google ScholarPubMed
Henrina, J, Putra, ICS, Lawrensia, S, et al. Coronavirus disease of 2019: a mimicker of dengue infection? SN Compr Clin Med. 2020. doi: 10.1007/s42399-020-00364-3 CrossRefGoogle ScholarPubMed
Yan, G, Lee, CK, Lam, LT, et al. Covert COVID-19 and false-positive dengue serology in Singapore. Lancet Infect Dis. 2020;20(5):536.CrossRefGoogle Scholar
Blanco-Melo, D, Nilsson-Payant, B, Liu, W-C, et al. SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems. BioRxiv. 2020. doi: 10.1016/j.cell.2020.04.026 Google Scholar
Butthep, P, Chunhakan, S, Yoksan, S, et al. Alteration of cytokines and chemokines during febrile episodes associated with endothelial cell damage and plasma leakage in dengue hemorrhagic fever. Pediatr Infect Dis J. 2012;31(12):e232-e238.Google ScholarPubMed
Miah, MA, Husna, A. Coinfection, coepidemics of COVID-19, and dengue in dengue-endemic countries: a serious health concern. J Med Virol. 2021;93(1):161-162.CrossRefGoogle ScholarPubMed
Ridwan, R. COVID-19 and dengue: a deadly duo. Trop Doct. 2020;50(3):270-272.Google ScholarPubMed
Joob, B, Wiwanitkit, V. COVID-19 can present with a rash and be mistaken for dengue. J Am Acad Dermatol. 2020;82(5):e177.CrossRefGoogle ScholarPubMed
Ludtke, JR, Narayan, R, Matariyeh, A, et al. Willingness to respond for radiologic incidents: a hands-on approach. Am J Disaster Med. 2014;9(4):259-272.CrossRefGoogle ScholarPubMed
Brannen, DE, Alhammad, A, Branum, M, et al. International air travel to Ohio, USA, and the impact on malaria, influenza, and hepatitis A. Scientifica (Cairo). 2016;2016:8258946.Google ScholarPubMed
Sultana, R, Alam, MS. Natural disasters and the dengue epidemic during COVID-19 outbreak are a deadly combination for public health threats in Bangladesh. Disaster Med Public Health Prep. 2020. doi: 10.1017/dmp.2020.493 Google ScholarPubMed
da Silva, SJR, de Magalhães, JJ, Pena, L. Simultaneous circulation of DENV, CHIKV, ZIKV and SARS-CoV-2 in Brazil: an inconvenient truth. One Health. 2020;12:100205.CrossRefGoogle Scholar
Iyengar, KP, Jain, VK, Ish, P. COVID-19 reinfection-an enigmatic public health threat. Monaldi Arch Chest Dis. 2020;90(4). doi: 10.4081/monaldi.2020.1596 CrossRefGoogle ScholarPubMed
Ministry of Health & Family Welfare, Government of India. Home :: National Vector Borne Disease Control Programme (NVBDCP). https://nvbdcp.gov.in. Accessed April 29, 2021.Google Scholar
Singh, N, Shukla, M, Chand, G, et al. Vector-borne diseases in central India, with reference to malaria, filaria, dengue and chikungunya. WHO South East Asia J Public Health. 2014;3(1):28-35.CrossRefGoogle ScholarPubMed
Desai, AN, Aronoff, DM. Masks and coronavirus disease 2019 (COVID-19). JAMA. 2020;323(20):2103.Google Scholar
Supplementary material: File

Venkatesh et al. supplementary material

Venkatesh et al. supplementary material

Download Venkatesh et al. supplementary material(File)
File 17.3 KB